The future of cancer clinical trials is promising, with advancements in technology and methodology. Personalized medicine, which tailors treatment to the individual's genetic profile, is becoming increasingly important. Additionally, the use of AI and big data is expected to streamline trial designs and improve efficiency. These innovations could lead to more effective treatments and faster approval processes.
